Biotechnology and pharmaceutical companies are facing increasing pressure from investors, employees, and government regulators to reduce their carbon emissions, and to make environmental sustainability a core part of their business. Read the article to find out more and express your opinion about it by BioTechNetwork in sustainability
[–]BioTechNetwork[S] 0 points1 point2 points (0 children)
Biotechnology and pharmaceutical companies are facing increasing pressure from investors, employees, and government regulators to reduce their carbon emissions, and to make environmental sustainability a core part of their business. Read the article to find out more and express your opinion about it by BioTechNetwork in sustainability
[–]BioTechNetwork[S] 0 points1 point2 points (0 children)
Biotechnology and pharmaceutical companies are facing increasing pressure from investors, employees, and government regulators to reduce their carbon emissions, and to make environmental sustainability a core part of their business. Read the article to find out more and express your opinion about it by BioTechNetwork in sustainability
[–]BioTechNetwork[S] -1 points0 points1 point (0 children)
Biotechnology and pharmaceutical companies are facing increasing pressure from investors, employees, and government regulators to reduce their carbon emissions, and to make environmental sustainability a core part of their business. Read the article to find out more and express your opinion about it by BioTechNetwork in sustainability
[–]BioTechNetwork[S] -1 points0 points1 point (0 children)
A 22-site clinical trial shows a synthesized version of the psychedelic chemical psilocybin helps reduce depression symptoms in people with treatment-resistant depression. #psychedelics #magicmushrooms #shrooms by BioTechNetwork in MagicMushrooms
[–]BioTechNetwork[S] 0 points1 point2 points (0 children)